The age-associated decline of androgens in reproductive age and menopausal Black and White women.

The age-associated decline of androgens in reproductive age and menopausal Black and White women. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The age-associated decline of androgens in reproductive age and menopausal Black and White women. Abstract Text:

Jessica B Spencer,Mitchel Klein,Ashim Kumar,Ricardo Azziz,Jessica B Spencer,Mitchel Klein,Ashim Kumar,Ricardo Azziz,Jessica B Spencer,Mitchel Klein,Ashim Kumar,Ricardo Azziz,

CONTEXT: The effect of race and obesity on the age-associated decline of androgens in reproductive-aged and menopausal women has not been well characterized. OBJECTIVE: Our objective was to determine the impact of racial differences and body mass index (BMI) on the change in androgen levels during a woman's reproductive and early menopausal years. DESIGN AND SETTING: We conducted a frequency-matched cross-sectional study at a tertiary academic medical center. PATIENTS OR OTHER PARTICIPANTS: Subjects included 260 healthy, nonhirsute and eumenorrheic, self-identified Black and White women, ages 15-60 yr. INTERVENTIONS: A medical and reproductive history, physical exam, and blood sampling were determined in the fasting state during the early follicular phase. MAIN OUTCOME MEASURES: Serum levels of androgens or androgen metabolites (dehydroepiandrosterone sulfate, androstenedione, and total and free testosterone) and SHBG were measured and the BMI, the waist-to-hip ratio (WHR), and the basal insulin resistance estimated by the homeostasis model assessment for insulin resistance determined. RESULTS: After controlling for differences in BMI, insulin resistance, and WHR, Black women had lower androgen levels than age-matched White women. All androgens, or androgen metabolites, declined similarly across the reproductive lifespan and menopausal transition in both Black and White women. Race was a significant predictor of dehydroepiandrosterone sulfate, androstenedione, and total and free testosterone but not SHBG. CONCLUSIONS: Eumenorrheic, nonhirsute Black women have a lower range of normal androgen levels than White women of the same age, BMI, WHR, and homeostasis model assessment index for insulin resistance. Race and age-adjusted data should be considered when evaluating androgen levels in women between the ages of 15 and 60 yr.

The age-associated decline of androgens in reproductive age and menopausal Black and White women. Publishing Authors By Initials

JB Spencer,M Klein,A Kumar,R Azziz,JB Spencer,M Klein,A Kumar,R Azziz,JB Spencer,M Klein,A Kumar,R Azziz,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The age-associated decline of androgens in reproductive age and menopausal Black and White women. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: The Journal of clinical endocrinology and metaboli

VOLUME: 92

Page Numbers: 4730-3

Journal Abbreviation: J. Clin. Endocrinol. Metab.

ISSN: 0021-972X

DAY: 25

MONTH: 09

YEAR: 2007

The age-associated decline of androgens in reproductive age and menopausal Black and White women. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375362

The age-associated decline of androgens in reproductive age and menopausal Black and White women. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The age-associated decline of androgens in reproductive age and menopausal Black and White women. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The age-associated decline of androgens in reproductive age and menopausal Black and White women.

AFFILIATION: Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, 8635 West Third Street, Suite 160W, Los Angeles, California 90048, USA.

Country: United States

AGENCY: United States NICHD

GRANT: R01-HD29364

ACRONYM: HD

MEDLINETA: J Clin Endocrinol Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The age-associated decline of androgens in reproductive age and menopausal Black and White women Related Publications

• Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
• Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters.
• Diagnosis of polycystic ovary syndrome.
• Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
• Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
• Impact of obesity on the risk for polycystic ovary syndrome.
• Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
• Nonreplication of the type 5 17 -hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
• Polycystic ovary syndrome is a family affair.
• Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005.
• Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome.
• The adrenal and polycystic ovary syndrome.
• The age-associated decline of androgens in reproductive age and menopausal Black and White women.
• The development of the polycystic ovary syndrome: family history as a risk factor.
• Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome.